Literature DB >> 21397979

Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule.

Adriana J Lammers1, Alexander P de Porto, Sandrine Florquin, Onno J de Boer, Hester J Bootsma, Peter W Hermans, Tom van der Poll.   

Abstract

Patients without a spleen are susceptible for overwhelming sepsis with Streptococcus pneumoniae. We investigated the relative contribution of the pneumococcal capsule in the reduced host defense after splenectomy. Sham-operated or splenectomized mice were inoculated with serotype 2 or 4 S. pneumoniae (D39, TIGR4) or the isogenic nonencapsulated mutants (D39Δcps, TIGR4Δcps). After splenectomy, intranasal infection with D39 resulted in increased mortality, increased bacterial dissemination and exaggerated systemic inflammation rather then altering inflammation in the lungs. Intravenous infection also resulted in enhanced mortality, bacterial growth and systemic inflammation after splenectomy. In contrast, the spleen did not contribute to host defense during infection with D39Δcps. Similar observations were made for TIGR4: increased bacterial growth and inflammation after intravenous infection with wild-type, but not nonencapsulated bacteria in splenectomized mice. These results indicate that the capsule of S. pneumoniae is indeed responsible for increased vulnerability of asplenic mice to invasive pneumococcal disease.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21397979     DOI: 10.1016/j.imbio.2011.02.004

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

1.  Modular Transcriptional Networks of the Host Pulmonary Response during Early and Late Pneumococcal Pneumonia.

Authors:  Brendon P Scicluna; Miriam H van Lieshout; Dana C Blok; Sandrine Florquin; Tom van der Poll
Journal:  Mol Med       Date:  2015-05-12       Impact factor: 6.354

2.  Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin.

Authors:  Jeffrey D Lebensburger; Thad Howard; Yunming Hu; Tamara I Pestina; Geli Gao; Melissa Johnson; Stanislav S Zakharenko; Russell E Ware; Elaine I Tuomanen; Derek A Persons; Jason W Rosch
Journal:  Blood       Date:  2011-11-30       Impact factor: 22.113

3.  Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis.

Authors:  Ahmed Achouiti; Thomas Vogl; Constantin F Urban; Marc Röhm; Tijmen J Hommes; Marieke A D van Zoelen; Sandrine Florquin; Johannes Roth; Cornelis van 't Veer; Alex F de Vos; Tom van der Poll
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

4.  Novel Mouse Model Reveals That Serine Phosphorylation of L-Plastin Is Essential for Effective Splenic Clearance of Pneumococcus.

Authors:  Edgar P Anaya; Xue Lin; Elizabeth M Todd; Taylor P Szasz; S Celeste Morley
Journal:  J Immunol       Date:  2021-04-15       Impact factor: 5.422

5.  Protective role of the capsule and impact of serotype 4 switching on Streptococcus mitis.

Authors:  Håkon V Rukke; Raja Sab Kalluru; Urska Repnik; Alice Gerlini; Ricardo J José; Jimstan Periselneris; Helina Marshall; Gareth Griffiths; Marco Rinaldo Oggioni; Jeremy S Brown; Fernanda C Petersen
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

6.  The polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in mice.

Authors:  Alex F de Vos; Mark C Dessing; Adriana J J Lammers; Alexander P N A de Porto; Sandrine Florquin; Onno J de Boer; Regina de Beer; Sanne Terpstra; Hester J Bootsma; Peter W Hermans; Cornelis van 't Veer; Tom van der Poll
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

7.  Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.

Authors:  Steven M Szczepanek; Sean Roberts; Kara Rogers; Christina Cotte; Alexander J Adami; Sonali J Bracken; Sharon Salmon; Eric R Secor; Roger S Thrall; Biree Andemariam; Dennis W Metzger
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

8.  Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.

Authors:  Tijmen J Hommes; Miriam H van Lieshout; Cornelis van 't Veer; Sandrine Florquin; Hester J Bootsma; Peter W Hermans; Alex F de Vos; Tom van der Poll
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

9.  Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo.

Authors:  Sacha F de Stoppelaar; Theodora A M Claushuis; Marianne C L Schaap; Baidong Hou; Tom van der Poll; Rienk Nieuwland; Cornelis van 't Veer
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae.

Authors:  Khalil Farhat; Gwennaëlle Bodart; Chantal Charlet-Renard; Christophe J Desmet; Michel Moutschen; Yves Beguin; Frédéric Baron; Pierrette Melin; Pascale Quatresooz; Anne-Simone Parent; Daniel Desmecht; Jean-Claude Sirard; Roberto Salvatori; Henri Martens; Vincent G Geenen
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.